OLER ABRAHAM N.
SEC CIK 1557372 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | SVP Corp Dev, Gen Counsel | 24.5K | $25.6K | — | 7 | 2021-09-28 | 2022-01-28 |
Most active insiders at TRAW, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 10% | $998.2K | — |
| 2 | Parker Charles Nolan | CFO | — | — |
| 3 | Redfield Robert | Chief Medical Off | — | — |
| 4 | Pauza Charles David | CSO Virology | — | — |
| 5 | Savchuk Nikolay | COO, Dir | — | — |
| 6 | Clarke Trafford | Dir | — | — |
| 7 | Shoemaker Mary Teresa | Dir | — | — |
| 8 | Dukes Iain D. | CEO, Dir | — | — |
| 9 | Leaman John Harold | Dir | — | — |
| 10 | CAUTREELS WERNER | Dir | — | — |
OLER ABRAHAM N. made no open-market trades at TRAW in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-31 | 2022-01-28 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $1.67 | +1,500 | 24.5K | +7% | +$2,505 | |
| 2022-01-24 | 2022-01-21 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $2.02 | +1,500 | 23.0K | +7% | +$3,030 | |
| 2022-01-18 | 2022-01-14 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP CORP DEV, GEN COUNSEL | P - Purchase | $2.20 | +1,500 | 21.5K | +7% | +$3,300 | |
| 2022-01-10 | 2022-01-07 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $2.39 | +1,500 | 20.0K | +8% | +$3,585 | |
| 2021-11-23 | 2021-11-19 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP CORP DEV, GEN COUNSEL | P - Purchase | $3.16 | +1,000 | 18.5K | +6% | +$3,160 | |
| D | 2021-11-19 | 2021-11-18 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | X - OptEx | $3.00 | +5,000 | 17.5K | +40% | +$15.0K |
| 2021-09-29 | 2021-09-28 | TRAW | Traws Pharma, Inc. | OLER ABRAHAM N. | SVP Corp Dev, Gen Counsel | P - Purchase | $4.20 | +2,381 | 12.5K | +23% | +$10.0K |
Purchase Sale Sale after option exercise All abbreviations